Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims Database

Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims Database

Background: It is thought that older patients with multiple sclerosis (MS) may present with a different clinical disease phenotype, and therefore respond to subcutaneous interferon beta-1a (sc IFN β-1a) differently to younger patients. However, few real-world data are available concerning the effect...

Full description

Bibliographic Details
Main Authors: Arthur Allignol, Emmanuelle Boutmy, Meritxell Sabidó Espin, Kurt Marhardt, Patrick Vermersch
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Neurology
Subjects:
adherence
age
healthcare utilization
subcutaneous interferon beta-1a
multiple sclerosis
relapse
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.676585/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.676585/full

Similar Items